23 results
8-K
EX-4.2
CNSP
Cns Pharmaceuticals Inc
2 Feb 24
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-4.1
CNSP
Cns Pharmaceuticals Inc
2 Feb 24
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-4.3
CNSP
Cns Pharmaceuticals Inc
2 Feb 24
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-4.1
tv8 2utjo968p5o6
17 Oct 23
Entry into a Material Definitive Agreement
8:00am
8-K
EX-4.1
h06 wmhs6
1 Dec 22
CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price
5:19pm
8-K
EX-4.3
k9z0uauzkg4pjh1
1 Dec 22
CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price
5:19pm
8-K
EX-4.2
op6f0p76m1a8aq1z
1 Dec 22
CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price
5:19pm
8-K
EX-4.2
enbkv926mq24ifd3a
6 Jan 22
CNS Pharmaceuticals Announces $11.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
9:11am
8-K
EX-4.1
npce05z 7r
6 Jan 22
CNS Pharmaceuticals Announces $11.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
9:11am
S-3
EX-4.1
0qk3n xaw
27 Jan 21
Shelf registration
4:02pm
S-3
EX-4.2
14j qkmu1wda1rr
27 Jan 21
Shelf registration
4:02pm
8-K
EX-4.1
y4lh4
28 Dec 20
CNS Pharmaceuticals Announces Pricing of $10.0 Million Public Offering
4:30pm